Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1947 of 6351
-
Could a heart pill slow a hidden dementia?
Disease control OngoingWidespread recognition of the current and projected impact of the dementia epidemic has spurred research into novel drug discovery efforts. It is well recognized by most that Alzheimer's disease is not the only form of dementia and that beginning to turn attention to other diseas…
Phase 2 • Sponsor: Gregory Jicha, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New Heartburn-Free heart fix? study tests cooled catheter for racing pulse
Disease control CompletedThe WATER ATTAC study aims at multicentric, longitudinal, perspective evaluation of safety and efficacy of atrioventricular nodal reentrant tachycardia (AVNRT) performed combining irrigated ablation catheter and three-dimensional electroanatomic mapping system. Efficacy and rate …
Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple heart scan save mothers and babies?
Diagnosis OngoingNon-obstetrical drivers of adverse pregnancy outcomes are underappreciated. Latent structural heart disease may account for a substantial proportion of adverse pregnancy outcomes in low-resource settings. Pregnant women presenting to B.P. Koirala Institute of Health Sciences wil…
Sponsor: Thomas Pilgrim • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Can simple positive activities boost Well-Being in cancer care?
Symptom relief CompletedPositive Activities for Asian American Cancer Patients and Caregivers
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New immunotherapy cocktail shows promise for Hard-to-Treat cancers
Disease control CompletedThe purpose of this study is to assess the safety, drug levels, immunogenicity and preliminary efficacy of BMS-986213 (nivolumab-relatlimab fixed-dose combination) in Chinese participants with advanced solid tumors.
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to find the best way to catch HPV cancers early in HIV patients
Diagnosis OngoingThis clinical trial aims to find what different tests work best to find high-grade squamous intraepithelial lesions (HSIL) in the cervix or anus in patients living with human immunodeficiency virus (HIV). Patients with HIV are at high risk of becoming infected with human papillom…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
Stem cell injection aims to heal tough fistulas in Crohn's patients
Disease control Recruiting nowThis study is a survey in Japan of Darvadstrocel injection used to treat Crohn's disease people with complicated anal fistula. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens duri…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple supplement reverse muscle wasting in liver disease?
Disease control Recruiting nowLoss of skeletal muscle mass or sarcopenia is the most common and potentially reversible complication in cirrhosis that increases morbidity and mortality before, during and after liver transplantation. No proven treatments exist for the prevention or reversal of sarcopenia in cir…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Weekly shot could replace daily insulin for diabetes
Disease control CompletedThis study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine taken daily with insulin aspart in people with type 2 diabetes.The study will look at how well IcoSema controls blood sugar level in …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control Stopped earlyThis is a study to understand if taking VTX002 daily as a tablet orally is safe and effective in participants diagnosed with moderate to severe ulcerative colitis (UC). Approximately 189 participants will take VTX002 Dose A, VTX002 Dose B, or matching placebo, once daily. The st…
Phase 2 • Sponsor: Oppilan Pharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug BL-B01D1 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowIn phase Ia study, the safety and tolerability of BL-B01D1 in patients with locally advanced or metastatic solid tumor will be investigated to determine the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) of BL-B01D1. In phase Ib study, the safety and tolerability of …
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a diabetes drug help prevent uterine cancer?
Disease control OngoingThis phase II trial studies the effect of megestrol acetate alone or in combination with metformin in preventing the progression of uterine pre-cancer (endometrial intraepithelial neoplasia) to endometrial cancer. Megestrol acetate is a drug used to block estrogen and suppress th…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for schizophrenia: valbenazine shows promise in phase 3 trial
Symptom relief CompletedThe primary objective for this study is to evaluate the effect of adjunctive valbenazine versus placebo on symptoms of schizophrenia in participants who have inadequate response to antipsychotic treatment.
Phase 3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Could a pill shrink nerve tumors in NF1? new trial aims to find out
Disease control Recruiting nowBackground: NF1 is a genetic disease that causes tumors called atypical neurofibromas. These tumors, which arise from nerves, can cause serious medical problems. The only treatment is surgery. Researchers want to see if a drug called abemaciclib can help. Objective: To find a …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Clip or coil? new study tests best way to stop stomach bleeding
Disease control Recruiting nowIn the management of patients with acute upper non-variceal upper gastrointestinal bleeding, further bleeding is the most important adverse factor predictive of mortality. In the United Kingdom Audit on acute upper gastrointestinal bleeding, clinical evidence of further bleeding …
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
One shot, two benefits: HIV treatment and contraception combined?
Disease control Recruiting nowThe study investigators are conducting foundational pharmacokinetic (PK) and qualitative studies, among 15-24 years old (inclusive) adolescent girls and young women living with HIV (AGYWLHIV) already on oral antiretroviral therapy (ART) and virally suppressed, leading up to a hyb…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control CompletedA Phase I/II Study of LM-302 in Patients with CLDN18.2-Positive Advanced Solid Tumors
Phase 1/2 • Sponsor: LaNova Medicines Zhejiang Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:40 UTC
-
New Four-Pronged antibody takes on advanced breast cancer
Disease control OngoingIn this study, the safety, tolerability and preliminary effectiveness of GNC-035 in participants with locally advanced or metastatic Breast Cancer will be investigated to assess the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for …
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New HIV vaccine combo passes early safety check in 34 volunteers
Vaccine CompletedThe purpose of this study is to evaluate the safety and immunogenicity of HIV-1 vaccines based on chimpanzee serotypes of adenovirus expressing clade C gp140 and a CH505TF gp120 protein boost in healthy, HIV- uninfected adult participants.
Phase 1 • Sponsor: HIV Vaccine Trials Network • Aim: Vaccine
Last updated Jun 27, 2026 08:06 UTC
-
Tailored scope schedule aims to cut cancer risk in FAP patients
Disease control Recruiting nowThe purpose of this study is to determine the efficacy and safety of a personalised surveillance and intervention protocol for patients with familial adenomatous polyposis (FAP) that have undergone (procto)colectomy.
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC